title: Ethnic difference may contribute to the efficacy of low-dose imatinib mesylate in systemic sclerosis.
authors.forename: Jing
authors.initials: J
authors.lastname: Tan
authors.forename: Jing
authors.initials: J
authors.lastname: Wei
mesh_terms: D005260:Female; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012595:Scleroderma, Systemic / Q000188:drug therapy* / Q000208:ethnology*
chemical_list: D010879:Piperazines; D011743:Pyrimidines